Drug Shortage Report for JAMP-SOLIFENACIN
Report ID | 160741 |
Drug Identification Number | 02424347 |
Brand name | JAMP-SOLIFENACIN |
Common or Proper name | Solifenacin Succinate Tablets |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | SOLIFENACIN SUCCINATE |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 (bottle) |
ATC code | G04BD |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-05-12 |
Estimated end date | 2022-11-10 |
Actual end date | 2022-11-04 |
Shortage status | Resolved |
Updated date | 2022-11-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2022-05-17 | French | Compare |
v1 | 2022-05-17 | English | Compare |